Vancomycin Exposure and Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid
A legfontosabb adatok
- Ki végzi
- Nutromics
- Hol
- New Hyde Park, New York, Oakland, San Francisco és Stanford (Egyesült Államok)Mind a 5 helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 200 fő, tervezett
- Kezdés
- 2026. dec.
- Várható befejezés
- 2028. dec.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A regiszteradat frissítve
- 2026. október 23.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 10 feltétel megnézéseKevesebb
Ki vehet részt
- Capable of providing informed consent OR has a Medical Treatment Decision Maker who can provide informed consent per the informed consent form (ICF)
- Aged 18 years at time of enrolment
- Prescribed vancomycin treatment for intravenous administration (Cohort 1 only); vancomycin treatment duration expected to be ≥48 hours from time of enrolment
- Has a central or arterial catheter and/or a large-bore cannula, or is willing to have intermittent peripheral blood sampling
Ki nem vehet részt
- Currently receiving an investigational drug or device that, in the Investigator's opinion, may affect participation in this trial
- History of allergic reactions to metals, plastics and adhesives which, in the opinion of the Study Investigators, would increase the risk of allergic reaction associated with the Device
- Dermatological (or other) condition, or fragile skin, which in the opinion of the Investigators would prevent application of the Nutromics Sensor Device
- Severe oedema or local swelling at the intended application site that would likely impair ISF sampling
- Immediate life-threatening instability where study procedures would interfere with urgent care (participant may be screened once stable)
- Pregnant, lactating, planning to become pregnant, breastfeed, or donate ova
Helyszínek itt: Egyesült Államok
- Northwell HealthNew Hyde Park, Egyesült ÁllamokToborzás még nem indult
- Columbia UniversityNew York, Egyesült ÁllamokToborzás még nem indult
- Kaiser PermanenteOakland, Egyesült ÁllamokToborzás még nem indult
- University of California San FranciscoSan Francisco, Egyesült ÁllamokToborzás még nem indult
- StanfordStanford, Egyesült ÁllamokToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this observational study is to understand whether a wearable sensor (the Nutromics Sensor Device) can accurately measure drug and biomarker levels in the fluid just under the skin (interstitial fluid), instead of needing repeated blood draws, in adults admitted to hospital who are being treated with the antibiotic vancomycin or who are being monitored for signs of sepsis. The main questions it aims to answer are:
A teljes eredeti leírásKevesebb
* How closely do interstitial fluid levels of vancomycin match levels measured in the blood at the same time? * How closely do interstitial fluid levels of creatinine, C-reactive protein, and lactate (biomarkers linked to kidney function, inflammation, and infection severity) match levels measured in the blood? * Can the device pick up on early biomarker trends that signal a patient may be developing acute kidney injury? * How well does the device work overall, and does it perform consistently across different patients (by age, sex, ethnicity, body size, and health conditions) and over time? * Is the device safe to wear?
There is no comparison group receiving a different treatment. This study looks at how well the device's readings line up with standard blood tests, not about testing a new treatment.
Participants will:
* Wear up to two small sensor patches on their upper arm during their hospital stay (up to 5 days), with each patch replaced every 48 hours * Have blood samples taken as part of their routine care so results can be compared * Have their medical records reviewed 30 days after finishing the study to check on their health outcomes
A vizsgálat 2 csoportja
- Cohort 1
Hospitalised participants receiving vancomycin (Vancomycin monitoring)
- Cohort 2
Hospitalised participants not receiving vancomycin (Biomarker Monitoring)
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Vancomycin Exposure, Nephrotoxicity, and Sepsis Biomarker Tracking Using Real-time Monitoring of Interstitial Fluid
- A regiszteradat frissítve
- 2026. október 23.